Emami Limited has delivered exceptional financial performance in Q3FY26, reporting consolidated net sales of ₹1,147 crore compared to ₹1,036 crore in the corresponding quarter of the previous year. The consumer goods company achieved consolidated net profit of ₹319 crore, marking a significant 15% increase from ₹279 crore in the same period last year.

Outstanding Financial Performance

The company's quarterly results demonstrate robust growth across all key financial metrics. Net sales growth of 11% year-on-year, combined with the 15% increase in net profit, showcases Emami's ability to drive both top-line and bottom-line expansion. The company reported EBITDA of ₹384 crore, representing a substantial 13% increase from ₹339 crore in the corresponding quarter of the previous year.

Exceptional Margin Expansion

Emami's EBITDA margin improved significantly to 33.4% in Q3FY26, compared to 32.3% in the same period last year, reflecting enhanced operational efficiency and superior cost management. This margin expansion of 110 basis points demonstrates the company's ability to optimize its cost structure while maintaining strong growth momentum across its business operations. Gross margins also expanded to 70.6%, an improvement of 30 basis points.

Strong Domestic and International Performance

The domestic business delivered growth of 11%, driven by robust volume growth of 9%. All major brands registered healthy performance during the quarter, with BoroPlus Range leading growth at 16%, followed by Kesh King Range at 10%, Pain Management Range at 8%, and Healthcare Range at 7%. The international business recorded sales growth of 9%, contributing 15% to overall sales, with strong performance across SAARC, MENA, and CIS regions.

Strategic Innovation and Product Launches

During the quarter, Emami launched several new products including Kesh King Gold Advanced Hair Growth Serum, BoroPlus Deeply Moisturising Lip Balm, Zandu Apple Cider Vinegar Effervescent Tablets, and Zandu Good Gut Constipation Relief Tablets. The Man Company introduced Vitamin C and Anti Acne Facewash, Moisturizing Gel Cream, and Anti Dandruff Shampoo, further strengthening its premium male grooming segment.

Regulatory Compliance and Publication

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Emami Limited published its unaudited financial results for the quarter and nine months ended December 31, 2025, in newspapers. The results were published in "Business Standard" (English Version) and "Aajkal" (Bengali Version) on February 5, 2026, following Board approval on February 4, 2026.

Interim Dividend Declaration

The Board of Directors declared a second interim dividend of 600%, amounting to ₹6 per share for FY26. With this declaration, the total dividend for the nine months ended FY26 stands at ₹10 per share, demonstrating the company's confidence in its financial strength and commitment to rewarding shareholders.

Source: Emami Limited Investor Presentation Q3FY26, Business Standard newspaper publication

Emami Limited , a prominent Indian consumer goods company, has witnessed significant share encumbrance activities by its major shareholders in January 2026. The latest regulatory filings reveal multiple share releases and new pledges by promoter entities Diwakar Finvest Private Limited and Suraj Finvest Private Limited.

January 2026 Transaction Activities

The promoter entities executed a series of share release and pledge transactions between January 7-14, 2026. These activities involved multiple financial institutions and resulted in net changes to the encumbered shareholding positions.

Current Shareholding Positions

Following the January 2026 transactions, the promoter entities maintain substantial stakes in Emami Limited:

Previous Transaction History

These recent activities follow earlier share encumbrance transactions from December 2025, which involved pledges to Bajaj Finance Limited:

Regulatory Compliance

All disclosures were made to the National Stock Exchange of India Limited and BSE Limited under Regulation 31(1) & (2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Santinath Paul, as the authorized signatory, submitted the required documentation on behalf of both promoter entities on January 15, 2026.

Market Context

The recent transactions demonstrate active portfolio management by Emami's promoter entities, involving both the release of existing encumbrances and creation of new pledges. These activities reflect ongoing financial arrangements with various institutional lenders while maintaining substantial unencumbered shareholdings in the company.